timolol maleate Nursing Considerations & Management

Drug Name

Generic Name : timolol maleate

Brand Name: Apo-Timol (CAN), Apo-Timop (CAN), Betimol, Blocadren, Gen-Timolol (CAN), Novo-Timol (CAN), Nu-Timolol (CAN), Timoptic, Timoptic-XE

Classification: Beta-adrenergic blocker, Antihypertensive, Antiglaucoma drug

Pregnancy Category C 

Dosage & Route

Available forms : Tablets—5, 10, 20 mg; ophthalmic solution, gel—0.25%, 0.5%



  • Hypertension: Initially, 10 mg bid. Increase dosage at 1-wk intervals to a maximum of 60 mg/day divided into two doses, as needed. Usual maintenance dose is 20–40 mg/day given in two divided doses.
  • Prevention of reinfarction in MI (long-term prophylaxis in patients who survived the acute phase): 10 mg bid PO within 1–4 wk of infarction.
  • Migraine: 10 mg PO bid; during maintenance, the 20 mg/day may be given as a single dose. May be increased to a maximum of 30 mg/day in divided doses or decreased to 10 mg/day. Discontinue if satisfactory response is not obtained after 6–8 wk.


  • Initially, 1 drop of 0.25% solution bid into the affected eye or eyes. Adjust dosage on basis of response to 1 drop of 0.5% solution bid or 1 drop of 0.25% solution daily. When replacing other agents, make change gradually and individualize dosage. One drop in the affected eye each morning (Istalol).
  • Safety and efficacy not established.
Therapeutic actions
  • Timolol is a non-selective β-adrenergic receptor blocker which does not have significant intrinsic sympathomimetic, direct myocardial depressant or local anesthetic activity. It decreases intraocular pressure by reducing aqueous humor formation or increase outflow.
  • Hypertension, used alone or in combination with other antihypertensives, especially thiazide-type diuretics
  • Prevention of reinfarction in MI patients who are hemodynamically stable
  • Prophylaxis of migraine
  • Ophthalmic solution: Reduction of IOP in chronic open-angle glaucoma, some patients with secondary glaucoma, aphakic patients with glaucoma ocular hypertension
Adverse effects
  • Fatigue, coldness of extremities, paresthesia, GI symptoms, skin rash, alopecia, dry mouth, bradycardia. Ophthalmic use: Blurred vision, burning, stinging, ocular irritation, decreased corneal sensitivity, visual disturbances, diplopia, ptosis, cystoid macular edema, pseudopemphigoid, choroidal detachment following filtration surgery. Systemic absorption with systemic effects may occur.
  • Potentially Fatal: Heart failure, heart block, bronchospasm, respiratory failure.
  • Present or history of bronchial asthma, COPD, present or history of bronchospastic disease, sinus bradycardia, 2nd and 3rd degree heart block, overt heart failure, cardiogenic shock. Pregnancy.
Nursing considerations
  • History: Sinus bradycardia, second- or third-degree heart block, cardiogenic shock, CHF, asthma, COPD, pregnancy, lactation, diabetes or thyrotoxicosis
  • Physical: Weight, skin condition, neurologic status, P, BP, ECG, respiratory status, renal and thyroid function, blood and urine glucose
  • WARNING: Do not discontinue drug abruptly after long-term therapy (hypersensitivity to catecholamines may have developed, causing exacerbation of angina, MI, and ventricular arrhythmias). Taper drug gradually over 2 wk with monitoring.
  • Consult with surgeon about withdrawal if patient is to undergo surgery (withdrawal is controversial).
Teaching points
  • Do not stop taking this drug unless instructed to do so by your health care provider.
  • Avoid driving or dangerous activities if dizziness or shaking occurs.
  • If using ophthalmic form, administer eye drops properly to minimize systemic absorption.
  • Report difficulty breathing, night cough, swelling of extremities, slow pulse, confusion, depression, rash, fever, sore throat.
Announcement!! Our hottest nursing game is out now in the App Store. Many nurses are playing now!LEARN MORE